MCK
$967.02-2.60%
as of close, Oct 27, 2026
☾ AH $967.02 -2.60%
MCK — McKesson Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
200.0300.0400.0500.0600.0700.0800.0900.01000.0050.0M100.0M$967.02—20162019202120242026
2026-10-27
Price$967.02
MA20$855.41
MA50$838.91
Vol2.4M
Key stats#
Price data
- Price
- $967.02
- YTD price return
- +17.89%
- YTD total return
- +18.24%
- Next earnings
- Nov 4, 2026 · After close
- Market cap
- 112.7B
- Enterprise value
- 120B
- Shares outstanding
- 116.6M
- 52W low
- $723.68
- 52W high
- $1,030.27
- From 52W high
- -6.14%
- From 52W low
- +33.63%
- 52W range
- 79%
- Beta
- 0.30
Volume
- Rel volume
- 0.76×
- 30D volume
- 767.9K
- 30D $ vol
- 711.7M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$797K
- Insider net 3M
- −$1.2M
- Insider net 1Y
- −$28.8M
Form 4 transactions by trade date, as filed; latest on file 2026-10-15.
Fundamentals
- Sales (ttm)
- 411B
- Sales/share
- $3,525.02
- EPS (ttm)
- $37.47
- FCF (ttm)
- 6.4B
- FCF/share
- $55.03
- Book value/share
- -$36.37
- Net margin
- 1.12%
- ROA
- 5.20%
- Current ratio
- 0.89
Growth (CAGR, ttm) · 10Y
- Sales
- +8.85%+13.10%+10.88%+7.85%
- Net income
- +45.17%+6.98%n/a+7.52%
- FCF
- +6.85%+11.32%+12.82%+3.41%
- Shares
- -6.27%-4.75%-5.50%-6.39%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +50.27%+11.80%n/a+14.57%
- Sales/share
- +16.13%+18.74%+17.33%+15.21%
- FCF/share
- +14.00%+16.86%+19.39%+10.47%
- Dividend/share
- +15.50%+14.94%+14.32%+11.35%
- Price
- +19.19%+29.23%+36.64%+19.81%
- Total return
- +19.66%+29.80%+37.35%+20.73%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 25.8×
- P/OI (ttm)
- 17.4×
- Fwd P/E
- 19.8×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- -26.6×
- P/FCF (ttm)
- 17.6×
- EV/EBITDA (fy)
- 16.5×
- EV/Sales (ttm)
- 0.3×
- FCF yield (ttm)
- 5.69%
- Dividend yield (fwd)
- 0.39%
- Dividend yield (ttm)
- 0.35%
- Dividend/share (fwd)
- $3.76
- Buyback yield (realized, 1y)
- 6.27%
- Shareholder yield (realized, 1y)
- 6.70%
- Buyback yield (cash, ttm)
- 5.94%
- Shareholder yield (cash, ttm)
- 6.29%
Vs own 10Y history
- P/E
- 51st
- P/OI
- 46th
- P/S
- 98th
- P/B
- 95th
- P/FCF
- 89th
Bar = where today’s multiple sits in MCK’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-2.60%
5D
-6.13%
1M
+11.58%
3M
+13.76%
YTD
+17.89%
1Y
+19.17%
5Y
+376.29%
Recent filings#
All filings and insider trades →Financial statements
Open full MCK financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
